Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

Yesterday, we tackled face coverings. Today, let's probe what researchers have learned about the efficacy of hydroxychloroquine and ivermectin in treating COVID-19. Feeling pressured by the ...

Hydroxychloroquine is a prescription drug that’s used to treat malaria, lupus, and rheumatoid arthritis. Medicare prescription drug plans cover hydroxychloroquine for its approved uses only. In ...

Trials have shown that ivermectin does nothing to prevent Covid patients from getting ill, while over 100 Americans died of the virus despite taking hydroxychloroquine in 2020 alone. Dr. Robert ...

Prolonged remission was observed in 72% of patients with systemic lupus erythematosus (SLE) who were treated with a consistent 200 mg daily dose of hydroxychloroquine. The mean weight-adjusted ...

Most physicians with experience in lupus agree that antimalarial treatments such as hydroxychloroquine (Plaquenil), chloroquine (Aralen) or quinicrine (Atabrine) should be used long-term, ...

Early initiation of hydroxychloroquine (HCQ) in patients with cutaneous lupus erythematosus (CLE) reduces the risk for progression to systemic lupus erythematosus (SLE) by 87% over time.